PROMAPAR Drug Patent Profile
✉ Email this page to a colleague
When do Promapar patents expire, and when can generic versions of Promapar launch?
Promapar is a drug marketed by Parke Davis and is included in five NDAs.
The generic ingredient in PROMAPAR is chlorpromazine hydrochloride. There are twenty-four drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the chlorpromazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Promapar
A generic version of PROMAPAR was approved as chlorpromazine hydrochloride by ZYDUS LIFESCIENCES on January 17th, 2020.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROMAPAR?
- What are the global sales for PROMAPAR?
- What is Average Wholesale Price for PROMAPAR?
Summary for PROMAPAR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 129 |
| Patent Applications: | 2,243 |
| DailyMed Link: | PROMAPAR at DailyMed |
US Patents and Regulatory Information for PROMAPAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke Davis | PROMAPAR | chlorpromazine hydrochloride | TABLET;ORAL | 086886-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Parke Davis | PROMAPAR | chlorpromazine hydrochloride | TABLET;ORAL | 086888-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Parke Davis | PROMAPAR | chlorpromazine hydrochloride | TABLET;ORAL | 084423-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Parke Davis | PROMAPAR | chlorpromazine hydrochloride | TABLET;ORAL | 086887-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
